Senior insider sale
Chief Medical Officer at MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$2.03M
75.33K shares
RODMAN DAVID MALCOM plans to sell 75.33K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $2.03M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of employee stock options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/14/2025 | Exercise of employee stock options Cash | 6.35K | — |
| Total | 6.35K | ||
Completed
Units to sell
14.06K
Market value
$387.7K
Units to sell
2.17K
Market value
$65.8K
Units to sell
4.58K
Market value
$114.6K
Units to sell
9.89K
Market value
$235.5K
Units to sell
6.35K
Market value
$151.9K
Units to sell
2.17K
Market value
$54.3K
Units to sell
417.00
Market value
$11.5K
Units to sell
14.06K
Market value
$401.8K
Units to sell
6.35K
Market value
$186.3K
Units to sell
2.17K
Market value
$64.5K
Units to sell
416.00
Market value
$13.0K
Units to sell
6.35K
Market value
$175.6K
Planned — Approximate Date
Units to sell
6.35K
Market value
$169.0K
Units
75.33K
Value
$2.03M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/13/2026 | 14.06K | $387.7K | — | Completed |
7/9/2026 | 2.17K | $65.8K | — | Completed |
6/17/2026 | 4.58K | $114.6K | — | Completed |
6/15/2026 | 9.89K | $235.5K | — | Completed |
6/12/2026 | 6.35K | $151.9K | — | Completed |
6/10/2026 | 2.17K | $54.3K | — | Completed |
5/18/2026 | 417.00 | $11.5K | — | Completed |
5/13/2026 | 14.06K | $401.8K | — | Completed |
5/12/2026 | 6.35K | $186.3K | — | Completed |
5/11/2026 | 2.17K | $64.5K | — | Completed |
4/17/2026 | 416.00 | $13.0K | — | Completed |
4/15/2026 | 6.35K | $175.6K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 6.35K | $169.0K | NASDAQ | Planned |
| Total | 75.33K | $2.03M | ||